MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617054872 A) filed by Pfizer Inc.; and Ctxt Pty Ltd on April 29, 2026, for Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives For The Treatment Of Cancer.
Inventors include Burtea, Alexander; Collins, Michael Raymond; Del Bel, Matthew L.; Greasley, Samantha Elizabeth; Johnson, Eric; Johnson, Ted William; Kumpf, Robert Arnold; Montgomery, Timothy Patrick; Ninkovic, Sacha; Rescourio, Gwenaella Christine; Richardson, Paul Francis; Scales, Stephanie Anne; Sutton, Scott Channing; and Kung, Pei-Pei.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The application relates to nitrogen-linked benzisoxazole sulfonamide derivatives or pharmaceutically acceptable salts thereof which act as Lysine Acetyl Transferase (KAT) inhibitors useful in the treatment of abnormal cell growth, such as cancer, in patients. Additional embodiments relate to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth, such as cancer, in patients.
Disclaimer: Curated by HT Syndication.
